Mr Hayden attended 2 days of learning courtroom skills and presentation of evidence in Manchester. Cross examination by a Bond Solon advocate was an experience to remember.
Mr Hayden has recently operated on a number of cases of HDGC syndrome where an inherited genetic mutation in CHD-1 (E-cadherin) predisposes to the development of stomach cancer. Affected individuals are recommended to under removal of the whole stomach (total gastrectomy) in order to improve long-term survival and prevent the development of advanced disease. When stomach cancer is caught at an early stage it can be cured.
In October 2015, Mr Hayden started providing weight loss surgery services for Healthier Weight (www.healthierweight.co.uk) with Specialist Consultations and Surgical Procedures performed at Spire Leeds Hospital. This partnership continues to grow with over 100 procedures performed from customers located in Yorkshire, The North-East of England and Scotland.
Mr Hayden managed to trek to the summit of Kilimanjaro in Tanzania in February 2016. After 18 months of preparation he managed to raise over £8000 for the Yorkshire Cancer Centre Appeal. It was a physically and emotionally demanding experience that surpassed all expectations.
The randomised-controlled trial of weight loss surgery ‘By-Band’ is funded to include sleeve gastrectomy as the third treatment option and now known as the ‘By-Band-Sleeve’ Trial. Leeds Teaching Hospitals is currently recruiting to this research study.
I was invited to the January meeting of the Oesophageal Patients Association at Headingley Golf Club a few weeks ago. I met a variety of courageous people who had their disease and its treatment in common. They had all survived and were determined to live a good quality of life and share their experiences with others and learn more about the disease and in particular advances in the treatment. Overall survival from oesophageal cancer is improving. Outcomes such as post-operative complications (problems that develop after surgery) and mortality (not-surviving the operation) are reducing in the UK since the National Oesophago Gastric Cancer Audit (NOGCA) started collecting data in 2006. Please visit http://www.augis.org/consultant-outcomes-publication-2014/ for more information.
We are pleased to announce that Leeds Teaching Hospitals has opened recruitment to the By-Band Randomised Controlled Trial. We have managed to recruit our first 3 patients into this important study. Thank you to all members of the teams in Leeds and Bristol for helping to get this off the ground in a relatively short time period.
I have recently decided to attempt a challenge of a lifetime and trek to the summit of Mount Kilimanjaro, the highest mountain in Africa. It will be a demanding walk spread out over 6-7 days to allow for altitude acclimatisation to try and reach the peak Kibo located 5895 metres (19341 ft) above sea level. I am raising funds for the Yorkshire Cancer Centre Appeal which supports patients with cancer in improving their quality of life. It also supports research projects and the purchase of vital medical equipment. A donation page has been set up (please copy into your browser). I am planning to do this Trek in February 2016.
Please visit this page for more information. All donations are gratefully received.
The first meeting tool place in St James’s Institute of Oncology, Leeds on 25th June 2014 to move forward plans to set up enhanced recovery for oesophageal and gastric cancer patients. The meeting was well attended by members of the multidisciplinary team and a overall a positive discussion was achieved. The process aims to improve the experience and outcome for patients who receive an operation to remove this type of cancer. Other units have demonstrated that some of the problems after surgery and the duration of stay in hospital may be reduced with adoption of this pathway. We look forward to visiting colleagues in Nottingham who have this already in place and hope that Leeds Teaching Hospitals will support plans to implement this proposal.
I was fortunate to have the opportunity to attend a meeting organised by Jane Blazeby in Bristol yesterday. She has obtained a National Institute for Health Research grant to investigate outcomes of weight loss surgery at 3 years. There is no conclusive good quality evidence to support the benefit of one weight loss surgery operation over another for patients with morbid obesity. This study is known as a ‘randomized-controlled trial’ where those patients who qualify for bariatric surgery, and are willing to participate, are allocated to gastric band or gastric bypass on a random basis. There is a possibility that sleeve gastrectomy could be included as a treatment option in the trial. The aim of ‘randomization’ is to reduce bias which can affect outcome reports in other types of studies. I hope to register Leeds as a study centre along with other bariatric units around the UK whose representatives also attended the meeting.